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EXPRESIÓN CIRCADIANA ESPECÍFICA DE LA
LOCALIZACIÓN DE LEPTINA Y SU RECEPTOR
EN TEJIDO ADIPOSO HUMANO
Resumen
Introducción: La variabilidad circadiana de los niveles
de leptina circulante se ha establecido en la última
década, pero actualmente se desconoce el comporta-
miento circadiano de leptina y su receptor en tejido adi-
poso (TA) humano.
Objetivo: Investigar si existe un comportamiento circa-
diano en la expresión de leptina y su receptor en TA
humano. 
Sujetos y métodos: Se obtuvieron biopsias de TA visce-
ral y subcutáneo abdominal de mujeres (n = 6) obesas
mórbidas (IMC  40 kg/m2). Se determinaron variables
antropométricas y concentraciones plasmáticas en ayu-
nas de glucosa, leptina, lípidos y lipoproteínas. Para
investigar los patrones de expresión rítmica de los genes,
se cultivaron explantes de TA durante 24-h y se analizó la
expresión génica a diferentes horas: 08:00, 14:00, 20:00,
02:00 h, usando PCR cuantitativa a tiempo real.
Resultados: La leptina mostró un patrón oscilatorio de
expresión comparable a un ritmo circadiano en TA culti-
vado. LEPR expresó patrones circadianos similares. La
leptina presentó su acrofase (máxima expresión) durante
la noche, pudiendo asociarse al bajo grado de acumula-
ción y elevada movilización de grasa. Cuando se compa-
ran ambos depósitos grasos, en el TA visceral se anticipó
la expresión hacia la tarde/noche. Fue interesante com-
probar, cómo los valores plasmáticos de leptina se asocia-
ron con una disminución de amplitud del ritmo de LEP,
pero al ajustar para la circunferencia de cintura, dicha
asociación desapareció. 
Conclusión: Demostramos ritmicidad circadiana de
leptina y su receptor en TA humano, siendo específica de
la localización adiposa. Estos descubrimientos preparan
el terreno para una mejor comprensión del papel auto-
crino/paracrino de la leptina en el TA humano.
(Nutr Hosp. 2011;26:1394-1401)
DOI:10.3305/nh.2011.26.6.5305
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Abstract
Introduction: Circadian variability of circulating lep-
tin levels has been well established over the last decade.
However, the circadian behavior of leptin in human adi-
pose tissue remains unknown. This also applies to the sol-
uble leptin receptor. 
Objective: We investigated the ex vivo circadian behav-
ior of leptin and its receptor expression in human adipose
tissue (AT). 
Subjects and methods: Visceral and subcutaneous
abdominal AT biopsies (n = 6) were obtained from morbid
obese women (BMI  40 kg/m2). Anthropometric variables
and fasting plasma glucose, leptin, lipids and lipoprotein
concentrations were determined. In order to investigate
rhythmic expression pattern of leptin and its receptor, AT
explants were cultured during 24-h and gene expression
was analyzed at the following times: 08:00, 14:00, 20:00,
02:00 h, using quantitative real-time PCR.
Results: Leptin expression showed an oscillatory pat-
tern that was consistent with circadian rhythm in cul-
tured AT. Similar patterns were noted for the leptin
receptor. Leptin showed its achrophase (maximum
expression) during the night, which might be associated
to a lower degree of fat accumulation and higher mobi-
lization. When comparing both fat depots, visceral AT
anticipated its expression towards afternoon and evening
hours. Interestingly, leptin plasma values were associated
with decreased amplitude of LEP rhythm. This associa-
tion was lost when adjusting for waist circumference. 
Conclusion: Circadian rhythmicity has been demon-
strated in leptin and its receptor in human AT cultures in
a site-specific manner. This new knowledge paves the way
for a better understanding of the autocrine/paracrine role
of leptin in human AT.
(Nutr Hosp. 2011;26:1394-1401)
DOI:10.3305/nh.2011.26.6.5305
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Introduction
Feeding is a crucial physiological function in ani-
mals and it responds circadian variability in food
availa bility.1 Leptin and other humoral signals pro-
duced in the peripherical tissues are capable of commu-
nicating the nutritional state of the organism to the
hypothalamic centres that control hunger and satiety, in
a circadian-dependent manner.2,3,4 Moreover there is
evidence showing the variability of leptin added by
factors such as obesity and sex,4 hormonal regulations,5
eating behaviours and sleep patterns.6
The ability of leptin to regulate food intake, body
weight, adiposity and insulin sensitivity has been
attributed exclusively to its actions in the hypothala-
mus.7 However, it has been suggested that leptin can
play important physiological roles in an autocrine/
paracrine way.8 The role of leptin on adipose tissue
(AT) has been reported to be essential in modulating
the adipocytes’ metabolic function, up-regulating fat
oxidation and decreasing lipogenesis.9 Leptin (LEP)
functions through a receptor (LEPR) expressed in adi-
pose tissue.10 Therefore, changes in LEP, or its receptor
in adipose tissue can be relevant in the development of
obesity and other metabolic disorders.4
The existence of an internal circadian clock has been
demonstrated in human adipose tissue.11 Moreover, cir-
cadian rhythmicity in cortisol-related genes,12 PPAR-
gamma12 and adiponectin,13 have been shown with a
different circadian behaviour between visceral and
subcutaneous AT depots. 
It has been discussed that abdominal fat accumulation
is related to chronodisruption.14 Given the potentially dif-
ferent roles of different fat depots,15 it is possible that their
metabolism is driven by different chronobiological
rhythms. Whereas many aspects of leptin metabolism
and variability have been intensively studied, less is
known about its circadian behavior in human adipose tis-
sue. Moreover the particular role of LEPR in adipocytes
is still unclear. Therefore, in this study we examined the
circadian behavior of LEP and its receptor in human adi-
pose tissue cultures, and the potential differences
between subcutaneous and visceral depots.
Subjects and methods
Subjects
Visceral and subcutaneous abdominal AT biopsies
were obtained from morbid obese women (n = 6), aged
51 ± 9 years and BMI: 44.1 ± 5.5 kg/m2, undergoing
laparoscopic gastric bypass surgery due to obesity at
the General Surgery Service of “Virgen de la Arrixaca”
Hospital (Murcia, Spain). The women studied were
postmenopausal and were not under hormone replace-
ment therapy. The day before surgery, all patients were
synchronized having lunch at 14:30 and dinner at 21:00
hours. The AT biopsies were taken as paired samples
from the two AT depots (visceral and subcutaneous) at
the beginning of the surgical procedure (estimated time
of biopsies sampling at 13:00 hours). 
The protocols were approved by the Ethics Commit-
tee of the “Virgen de la Arrixaca” University Hospital,
and the subjects signed a written informed consent
before the biopsies were obtained.
Clinical characteristics
Arterial pressure, BMI, waist and hip circumference
were assessed by standard procedures, while skinfolds
(biceps, triceps, suprailiac and subscapular) were mea-
sured with a Harpenden caliper (Holtain Ltd, Bryberian,
Crymmych, Pembrokeshire, UK). Total body fat (%)
was evaluated by bioimpedance with a TANITA TBF-
300 (TANITA Corporation of America, Arlington
Heights, IL). Sagittal diameter and coronal diameter
were measured at the level of the iliac crest (L4-5) using a
Holtain Kahn Abdominal Cali skinfold. Those patients
with VA/SA > 0.42 were classified as having visceral
obesity16. Fasting plasma concentrations of glucose, tria-
cylglycerols, total cholesterol and high-density lipopro-
tein (HDL) cholesterol were determined with common
analytical methods (Roche Diagnostics GmbH,
Mannheim, Germany). Basal plasma leptin levels were
measured using a a gamma counter (DPC Gambyt, city
and country) and RIA kits from Mediagnost Laboratory
(Reutlinge, Germany) with a sensitivity of 0.5 ng/ml and
intra assay CV of 8.3%. Basal metabolic Rate (BMR)
was calculated from the Harris and Benedict equation.17
Adipose tissue culture
Immediately after the surgery, a part of AT biopsies
were immediately frozen at -80ºC and used for analyz-
ing the basal gene expression. The rest of AT was used
for culture, thus 800-1,000 mg AT explants (minimal
pieces of 1-2 mm3 in order to allow the maximal con-
tact of adipose tissue with the medium) were trans-
ferred to cell culture bottles with membrane filter
screw cap to safeguard the viability of the culture, and
placed in 5 ml of Dulbecco’s modified Eagles Medium
Human adipose tissue leptin circadian
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(DMEM) supplemented with 10% fetal bovine serum,
and kept at 37º C for 24 hour in a humidified atmos-
phere containing 7% CO2.
On the next day, the adipose explants were collected
to perform gene expression analysis at the following
times (T): 0, 6, 12, and 18, T0 being arbitrarily defined
as 08:00 h, because this was the usual waking time for
patients, T6 as 14:00 h, T12 as 20:00 h and T18 as
02:00 h. Gene expression was measured only for one
circadian cycle (24 hours), but in the second day of cul-
ture. All cultures were performed in duplicate.
Analysis of gene expression
Total RNA was extracted from AT explants using
RNeasy Kit (QIAGEN, Courtabeouf, France). Reverse
transcription was performed using random hexamers
as primers and Thermoscript® reverse transcriptase
(Invitrogen, Cergy Pontoise, France) with 1 g total
RNA for each sample. Quantitative real-time PCR was
performed using an ABI PRISM 7000 HT Sequence
Detection System (Applied Biosystems, CA, USA),
using TaqMan® Universal PCR Master Mix and spe-
cific TaqMan probes (Applied Biosystems, CA, USA).
The primers used in the study are the following refer-
ences from Applied Biosystems: Human leptin
(Hs00174877_m1) and leptin receptor (Hs00174497_
m1). Hs00174497_m1 recognizes the main leptin
receptor isoforms (1, 2 and 3). 
We used PPIA rRNA (reference Hs99999904_m1
from Applied Biosystems) as internal control. We
selected PPIA because this gene showed a lower vari-
ance along time compared with the 18S gene. In addi-
tion, we carried out a one-way (Zeitgeber time, ZT)
analysis of variance (ANOVA) for PPIA and observed
no significant difference in any of the adipose depots
studied (P > 0.05). Gene mRNA levels were normal-
ized to PPIA using the 2− Ct method.18
Rhythm calculation and statistical analysis
Clinical and anthropometric data are presented as
means ± SD. The results for gene expression,
expressed in arbitrary units, are presented as means ±
SEM. Wilcoxon non parametric paired test was used
for comparing data from the samples derived from the
two adipose depots in each subject. Pearson’s correla-
tions coefficients were used for analyzing associations
between the relative expression of LEP and LEPR in
both adipose depots. 
The single cosinor method was used to analyze for cir-
cadian rhythm individually.19 This inferential method
involves fitting a curve of a predefined period by the least
squares method. The rhythm characteristics and their
95% confidence intervals estimated by this method
include the mesor (middle value of the fitted cosine repre-
senting a rhythm-adjusted mean), the amplitude (half the
difference between the minimum and maximum of the
fitted cosine function), the temporal location of maxi-
mum value or acrophase (the time at which the peak of a
rhythm occurs, expressed in hours) and the Percent
Rhythm (PR; the percentage of variability accounted for
by cosine curve). Relative amplitude was expressed as a
percentage of mesor values (relative amplitude = (ampli-
tude/mesor) x 100). The significance of the rhythms was
determined by rejection of the zero amplitude hypotheses
with a threshold of 60%. 
Mean circadian gene expression of the total popula-
tion into each fat depot was analyzed by using repeated
measures ANOVA test, with a post hoc test of least sig-
nificant difference (LSD) correction. Pearson’s corre-
lation analyses were used for finding associations
between the genetic circadian oscillation (amplitude
and percentage of variability) and components of the
MetS. All statistical analyses were carried out using
SPSS for windows (release 15.0; SPSS Inc, Chicago,
US). The level of significance for all statistical tests
and hypotheses was set at P < 0.05.
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Table I
General characteristics of the population studied
Patients (n = 6)
Age (y) 51 ± 9
Weight (kg) 107.9 ± 11.2
Height (cm) 156 ± 5.0
BMI (Kg/m2) 44.1 ± 5.5
Body fat (%) 43 ± 6
WC (cm) 126 ± 8
HC (cm) 139 ± 9
WHR 0.91 ± 0.03
Sagittal Diameter (cm) 22 ± 4
Coronal Diameter (cm) 31 ± 4
Bicipital skinfold (mm) 28 ± 3
Tricipital skinfold (mm) 28 ± 4
Subscapular skinfold (mm) 33 ± 4
Suprailliac skinfold (mm) 31 ± 3
BMR (Kcal) 1721 ± 120
VA/SApredicted 0.54 ± 0.28
Leptin (ng/ml) 40.66 ± 16.14
Glucose (mmol/l) 6.13 ± 0.82
Cholesterol (mmol/l) 4.53 ± 1.02
Triglycerides (mmol/l) 1.02 ± 0.42
HDL-cholesterol (mmol/l) 1.34 ± 0.22
LDL-cholesterol (mmol/l) 3.14 ± 0.68 
Systolic Pressure (mmHg) 148. ± 23
Diastolic Pressure (mmHg) 73 ± 14
Data are presented as means ± SD. BMI: Body Mass Index. WC:
Waist circumference. HC: Hip Circumference. WHR: Waist to Hip
Ratio. BMR: Basal Metabolic Rate. VA/SApredicted: Visceral Area/Sub-
cutaneous Areapredicted16. HDL: high-density lipoprotein; LDL: low-
density lipoprotein.
Human adipose tissue leptin circadian
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Results
Characteristics of the population
Table I contains baseline characteristics of the
women studied. They were morbidly obese (BMI > 40
kg/m2) primarily due to visceral obesity (VA/SA >
0.4). Moreover, they had metabolic syndrome, accord-
ing to the International Diabetes Federation (IDF) cri-
teria20. The individual and average values for waist cir-
cumference, glucose and systolic pressure exceeded
the cut off points proposed by IDF.
Basal gene expression
Paired adipose tissue biopsies from the subcutaneous
and visceral depots were obtained from each patient.
Basal gene expression for LEP and its receptor were sig-
nificantly different between AT depots (fig. 1). LEP
expression was higher in subcutaneous than in visceral
fat (P = 0.028), whereas LEPR expression was higher in
visceral fat (P = 0.028) (fig. 1). In both fat depots, LEP
was much more expressed than its receptor (3.6 times
more in visceral and 9.0 times in subcutaneous AT) (fig.
2). Correlation analysis showed a significant negative
Fig. 1.—Basal gene expression in both adipose depots. Basal
relative expression of genes studied (leptin (LEP) and leptin re-
ceptor (LEPR)) in subcutaneous (S) and visceral (V) adipose
tissue (AT) are showed. mRNA levels were measured with the
Real-Time PCR and normalized to PPIA using the ΔΔCt method
of relative quantization. Data are reported as means ± SEM
(Standard Error of the Mean). For leptin results are presented
as percent of VAT relative expression (VAT value = 1) and for
LEPR are presented as percent of SAT relative expression (SAT
value = 1). Asterisk (*) represents significant differences
(Wilcoxon non parametric paired test).
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Fig. 2.—Basal gene expression of genes studied within each fat
depot. Basal relative expression of genes studied (leptin (LEP)
and leptin receptor (LEPR)) within subcutaneous (S) and vis-
ceral (V) adipose tissue (AT) are compared. mRNA levels were
measured with the Real-Time PCR and normalized to PPIA us-
ing the ΔΔCt method of relative quantization. Data are reported
as means ± SEM (Standard Error of the Mean). The results are
presented as percent of LEPR relative expression in both depots
(LEPR value = 1). Asterisk (*) represents significant differ-
ences (Wilcoxon non parametric paired test)
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Table II
Parameters imputed from cosinor analysis
Subcutaneous Adipose Tissue Visceral Adipose Tissue
Patients
Mesor Amplitude Relative Acrophase % Mesor Amplitude Relative Acrophase %Amplitude Variance Amplitude Variance
LEP
P1 1.70 0.55 32.35 19.15 83.65 1.69 0.63 37.27 13.43 60.00
P2 1.53 0.39 25.49 17.16 76.67 1.28 0.28 21.87 13.01 99.40
P3 1.69 0.88 52.07 20.96 98.43 1.27 0.28 22.04 13.64 60.66
P4 1.87 0.46 24.59 3.21 25.22 1.59 0.60 37.73 15.70 74.87
P5 1.59 0.35 22.01 15.29 38.19 2.30 1.32 57.39 9.98 97.16
P6 0.99 0.22 22.22 12.28 97.00 1.90 1.01 53.15 10.55 99.78
LEPR
P1 2.24 2.18 97.32 17.72 67.03 9.19 10.58 115.12 23.90 47.28
P2 1.42 0.36 25.35 1.09 38.89 1.75 1.18 67.42 18.35 79.76
P3 1.46 0.17 11.64 16.42 8.96 2.22 1.15 51.80 21.21 83.18
P4 2.41 2.29 95.02 6.22 77.19 1.42 0.58 40.84 12.48 87.22
P5 1.81 1.03 56.90 3.70 90.74 1.42 0.26 18.30 2.43 31.09
P6 2.94 3.31 112.58 0.32 74.85 2.05 1.41 68.78 1.53 80.26
Parameters imputed from each subject obtained by cosinor analysis defining the circadian rhythms as mesor, amplitude, relative amplitude, acrophase and percent rhythm are repre-
sented in this table. Subjects in which expression of the gene was considered to have circadian rhythmicity are shown in bold. AU: Arbitrary units, h: hours.
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association between basal LEP expression and percent-
age of fat-free mass in subcutaneous AT (r = -0.844; P =
0.032) while LEPR was inversely correlated to percent
body fat (r = -0.87; P = 0.024), and total fat mass (r = -
0.90; P = 0.017). In visceral AT, LEPR expression corre-
lated inversely with BMR (r = -0.90; P = 0.017).
LEP and LEPR circadian gene expression
Next, we examined their circadian expression pat-
tern in cultured adipose tissue explants. Parameters
imputed from each subject obtained by cosinor
analysis, defining the circadian rhythms as mesor,
Fig. 3.—Circadian rhythms
and phase map of all genes
studied in total population.
Rhythmic expression and
phase map of genes studied
in human subcutaneous (3A)
and visceral adipose tissue
(3B). Adipose depots were
isolated at 6-h intervals over
the course of the day from
adipose tissue cultures (time
at 0, 6, 12 and 18 hours).
Results are presented rela-
tive to the lowest basal rela-
tive expression for each
gene. Data of relative ex-
pression are represented as
Arbitrary Units (AU). Data
are reported as means ±
SEM (SEM of ΔCt are repre-
sented in parenthesis). The
phase map shows the
acrophase (time of occur-
rence of the best-fit maxi-
mum value) and relative am-
plitude of circadian rhythms
of genes studied. The mean
values of achrophases are
plotted ± SEM.
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amplitude, relative amplitude, acrophase and per-
cent rhythm are reported in table II. Our data show
that the expression of both genes showed circadian
patterns.
Figure 3 shows mean LEP and LEPR circadian
rhythms in subcutaneous (3A) and visceral AT (3B).
When relative gene expression among different times
was analyzed by using repeated measures ANOVA
test, statistical differences were found for LEP in vis-
ceral depot (P = 0.004) and the same trend was found in
subcutaneous AT (P = 0.067), evidencing the circadian
rhythmicity of LEP expression. 
When comparing both AT depots, different circa-
dian patterns were observed. In subcutaneous depot,
LEP showed its achrophase (maximum expression)
during the night (at 02:00 hours) whereas in visceral
AT anticipated its expression in the evening (20:00
hours). On the other hand, LEPR displayed its
achrophase during the night in visceral and subcuta-
neous depots (at 08:00 and 04:00 hours respectively).
Similarly to the pattern observed for LEP, the receptor
achrophase (LEPR) was advanced in visceral with
respect to subcutaneous AT (fig. 3). 
Correlation analyses between the genetic circadian
oscillation (relative amplitude and percentage of vari-
ability) and components of the MetS are shown in
table III. We found a positive correlation between
obesity (sagittal and coronal diameter, body mass
index (BMI), weight, fat mass and body fat), plasma
glucose and low HDL-colesterol correlated with the
relative amplitude and higher variability of the circa-
dian rhythms for LEP and LEPR. When correlation
analysis were performed between the LEP rhythm’s
amplitude in visceral AT and leptin plasma values a
significant and inverse correlation was observed (r = -
0.843; P = 0.035). Interestingly, the significance was
lost when data was adjusted for waist circumference.
Moreover, we found an interesting negative correla-
tion between the circadian oscillation of LEP expres-
sion (relative amplitude) in subcutaneous AT and age
(r = -0.855; P = 0.030). 
Discussion
In this study we have demonstrated that: 1. LEP and
LEPR display 24-hr rhythmicity in cultured human adi-
pose tissue. 2 Basal gene expression for LEP and its
receptor were significantly different between AT
depots. 3. The circadian expression pattern of leptin is
site-specific. 4. Leptin plasma values were associated
with decreased amplitude of LEP rhythm. This associa-
tion was influenced by abdominal obesity. 
Similarly to our results, previous studies have ana-
lyzed LEP expression and shown that LEP mRNA was
two- to threefold higher in subcutaneous vs. omental
AT.21 The significantly higher expression of LEPR in
visceral fat, and of LEP in subcutaneous fat, could be
related to a differentiated LEP function in both locations,
suggesting an endocrine role in subcutaneous, and an
autocrine/paracrine predominance in visceral AT. More-
over, BMR could be linked to obesity-related leptin
resistance. This result suggests that an overproduction of
LEP, as occurs in obese subjects, could downregulate
the expression of LEPR in adipose tissue. As other
authors have reported7, high-fat diet induced-obesity
induced changes in LEPR expression in a depot and sex-
dependent manner in rats. Thus, they found a downregu-
lation of LEPR in retroperitoneal AT in men (not in
female) that they associated with a decrease in leptin
sensitivity in the obese subjects and a higher tendency to
suffer from obesity-related disorders.
In the women studied, AT LEP expression showed
circadian rhythmicity. Of note, LEP mRNA levels
fluctuated during the day in synchrony with its recep-
tor, suggesting the relevance of this rhythm in adipose
tissue.
Ando et al.22, demonstrated the rhythmic mRNA
expression of LEP in visceral AT in mice. Conversely,
in murine pre-adipocyte 3T3-L1 cell line, Otway et al.23
were not able to observe circadian rhythm of LEP
mRNA expression, though LEP accumulation in the
culture medium suggested circadian control of LEP
secretion from adipocytes. 
Table III
Correlations between the gene expression, circadian oscillation [relative amplitude (3A) and percentage of variability (3B)]
and components of the metabolic syndrome in visceral (V) and subcutaneous (S) adipose tissues (AT)
3A. Relative Amplitude
BMI (kg/m2) Sagital diameter (cm) Glucose (mg/dl) HDL-c (mg/dl)
r p r p r p r p
LEP (SAT) -0.841 0.036 -0.925 0.008 -0.638 0.247 -0.484 0.409
LEPR (SAT) -0.518 0.292 -0.727 0.102 -0.889 0.044 -0.094 0.881
LEPR (VAT) -0.197 0.708 -0.198 0.707 -0.312 0.610 -0.954 0.025
3B. Percentage of variability BMI (kg/m
2) Coronal diameter (cm) Weight (kg) Body fat (%) Fat mass (%)
r p r p r p r p r p
LEP (SAT) 0.904 0.013 0.911 0.012 0.904 0.013 0.378 0.473 0.646 0.166
LEPR (VAT) 0.302 0.561 0.074 0.889 0.441 0.381 0.972 0.001 0.868 0.025
Significant correlations (P < 0.05) are shown in bold.
Our results demonstrated that LEP had its achrophase
during the evening and night, with a similar pattern to
that formerly shown in plasma, where circulating leptin
peaks occurred during the sleep phase between 22:00-
03:00 h and nadirs during the morning hours between
08:00 and 17:00.4,24,25 In fact, Chin-Chance et al.26
demonstrated the zenith occurring at 02:00 h, coinci-
dent with our own results in AT. Furthermore, the rela-
tive amplitudes for leptin were similar for their study
(31%) and ours (30%). Although, this amplitude
appears to be higher than in other studies using several
organs or tissues,27 it was significantly lower to that
described in the same population for clock genes,11 glu-
cocorticoid-related genes12 and PPAR-gamma.12
The significance of the daily peaks and valleys in
leptin secretion in the hypotalamic regulation of body
weight in humans is not fully understood. Flier28 pro-
poses that leptin, rather than an antiobesity hormone,
acts as an integrator of neuroendocrine function, sig-
naling energy deficiency. Accordingly, the increase in
leptin during the night may mean that it acts as a satiety
hormone, favouring fasting and nocturnal rest. Other
authors defend that the nocturnal rise of leptin secre-
tion is entrained to mealtime probably due to cumula-
tive hyperinsulinemia of the entire day.29
With respect to AT, the achrophase at night could be
associated to a lower degree of fat accumulation and
higher mobilization. During the night in humans, there
is a predominance of lipolytic activity, responsible of
the body fat utilization, which reduces the frequency of
hunger signals and, in consequence, reduces the need
for food30. Indeed, the autocrine/paracrine role of leptin
on AT has been reported to be up-regulating fat oxida-
tion and decreasing lipogenesis.9
When comparing both AT depots, visceral AT antic-
ipated its expression towards afternoon and evening
hours (20:00 hours). It has been described that both the
sympathetic and parasympathetic division of the
autonomous nervous system can discriminate between
different compartments of AT, such as the subcuta-
neous and intraabdominal.31 Previously, it has been
reported a difference in the timing of the circadian
rhythm in circulating leptin as a function of body fat dis-
tribution (android versus gynoid), also showing different
association with respect to insulin and cortisol.32 An
imbalance between the rhythms of different fat compart-
ments differentially controlled by the autonomous ner-
vous system and in turn by the supraquiasmatic nucleus
may be related to Metabolic Syndrome (MetS).33
Aging has been associated with decreased relative
amplitude of the circadian rhythm.34 However, one sur-
prising result in the current data is that higher obesity
degree correlated with an increase in relative amplitude
and with higher variability of the circadian rhythms of
both genes studied. A similar situation happened when
comparing visceral and subcutaneous AT, with higher
relative amplitude in the visceral depot. Although these
results should be considered with caution, because
multiple comparisons test, the higher circadian
response of these genes in visceral AT could be related
to the deleterious effect of intraabdominal fat in rela-
tion to the risk for diabetes, cardiovascular disease,
hypertension, and certain cancers.35 Our data also indi-
cated that Leptin plasma values were associated with a
decreased amplitude of LEP rhythm, Interestingly, sig-
nificance was lost when adjusting for waist circumfer-
ence suggesting that abdominal fat is related to the
decreased in amplitude with leptin.
These results in LEP and its receptor LEPR contrast
to those obtained previously for adiponectin13 and for
clock genes in human adipose tissue11 and with the cur-
rent chronodisruption theory, which sustains that obe-
sity alter circadian rhythmicity towards a more flatten-
ing pattern.14 Consistent with our findings, Ando et
al.,22 using mouse visceral fat reported that for clock
genes and different adipokines circadian rhythmicity
was flattened with obesity, but not so for leptin. Simi-
larly, Bergman et al.,35 concluded in their previous
work performed in plasma that “leptin pulsatility can
be preserved in the obese”. 
One limitation of the current study was the lack of a
control group. Further studies in AT comparing data
from obese and lean subjects should be performed to
answer this question. However, we could speculate
from the current data that in the same way that LEP
expression and secretion are augmented with obesity,36
the positive correlation between rhythmicity and obe-
sity obtained in the current study, could be related to
leptin resistance. 
In conclusion, circadian rhythmicity has been
demonstrated in LEP and LEPR in human adipose tis-
sue cultures in a site-specific manner. These discover-
ies suggest that in AT metabolism it is imperative not
only to understand the “what” and the “how” but also
the “when” of these metabolic processes. A new obser-
vation point should be developed: a chronobiological
view of adipose tissue and obesity.
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